2021
DOI: 10.3389/fpain.2021.690683
|View full text |Cite
|
Sign up to set email alerts
|

Headache Medicine Grand Challenge: Headache: A New Frontier, A New Challenge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 74 publications
0
1
0
Order By: Relevance
“…This headache disorder is typically characterised by recurrent episodic attacks, moderate‐to‐severe headaches and associated clinical symptoms, such as photophobia, phonophobia, nausea and vomiting (Headache Classification Committee of the International Headache Society (IHS), 2013). Recently, drug therapies, such as calcitonin gene‐related peptide and triptans, for migraine have rapidly advanced (Freitag, 2021; Scuteri et al, 2019), providing a relatively effective response. However, these drugs are still unavailable to a large proportion of the population.…”
Section: Introductionmentioning
confidence: 99%
“…This headache disorder is typically characterised by recurrent episodic attacks, moderate‐to‐severe headaches and associated clinical symptoms, such as photophobia, phonophobia, nausea and vomiting (Headache Classification Committee of the International Headache Society (IHS), 2013). Recently, drug therapies, such as calcitonin gene‐related peptide and triptans, for migraine have rapidly advanced (Freitag, 2021; Scuteri et al, 2019), providing a relatively effective response. However, these drugs are still unavailable to a large proportion of the population.…”
Section: Introductionmentioning
confidence: 99%